Showing results (1-10 of 150) with videos related to
Sort By:
Pageof 15
F1000Research|March 24, 2018
Renal cell carcinoma: a review of biology and pathophysiologyShahzaib Nabi, Elizabeth R Kessler, Brandon Bernard, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2019
NCCN Guidelines Updates: Management of Muscle-Invasive Bladder CancerThomas W FlaigJournal of the National Comprehensive Cancer Network : JNCCN|May 23, 2018
The Changing Treatment Landscape for Metastatic Urothelial CarcinomaThomas W FlaigAdvances in Urology|March 31, 2012
Redefining hormone sensitive disease in advanced prostate cancerXiaoyu Hou, Thomas W FlaigInternational Braz J Urol : Official Journal of the Brazilian Society of Urology|July 7, 2010
Novel targeted agents for the treatment of bladder cancer: translating laboratory advances into clinical applicationXiaoping Yang, Thomas W FlaigExpert Opinion on Pharmacotherapy|December 2, 2010
Adjuvant medical therapy for prostate cancerChristopher Sumey, Thomas W FlaigOncology (Williston Park, N.Y.)|February 8, 2011
A renaissance in the medical treatment of advanced prostate cancerKyle O Rove, Thomas W FlaigCurrent Drug Targets|June 6, 2015
The Epidemiological, Mechanistic and Potential Clinical Role of Androgen Receptor (AR) in Urothelial CarcinomaMaria T Bourlon, Thomas W FlaigCancer Investigation|August 31, 2006
Mitoxantrone-associated acute myelogenous leukemia in a patient with high-risk adenocarcinoma of the prostate: a case report and brief reviewDaniel W Bowles, Thomas W FlaigOncology (Williston Park, N.Y.)|December 18, 2015
Upfront Chemotherapy for Metastatic Prostate CancerElaine T Lam, Thomas W FlaigPageof 15